TMCI

#3862
Treace Medical Concepts, Inc. Common Stock
2.13 USD
+5.97%
版块: 医疗保健
基础: USD
利润货币: USD
日范围
2.13
2.13
年范围
1.17
7.78
日变化
+5.97%
每月变动
+43.92%
6个月变化
-65.65%
年变化
-67.73%
前一天收盘价
2.01
开盘价
2.13
买价
卖价
最低价
2.13
High
2.13
交易量
66
展开完整图表

Financials

概览 声明 统计
每季度 年度
  • Market Capitalization 137.58 M
  • Employee 450
  • Founded 2014
  • CEO N/A
  • Website www.treace.com
  • Headquarter Florida, United States
  • FIGI BBG00GQKR6M4
  • Industry Technology
总收入
净利润
每股基本收益（基本 EPS）
总债务
自由现金流
现金及现金等价物
市盈率
-2.63
市销率
0.73

Treace Medical Concepts Inc

Treace Medical Concepts, Inc. is a medical device company, headquartered in Ponte Vedra Beach, Florida, specializing in the design, manufacture, and marketing of foot and ankle surgical devices and biologics. Lapiplasty, Treace’s novel primary surgical product, advanced the treatment of bunions, surgically correcting the metatarsal bone, for the first time, in all three dimensions. In March 2021, Treace announced its intent to launch an initial public offering. Trading on the Nasdaq under the ticker symbol “TMCI”, Treace opened its IPO in April 2021.

新闻